Thymopentin

DB11996InvestigationalSmall molecule

Thymopentin has been used in trials studying the treatment and prevention of HIV Infections and Hepatocellular Carcinoma.

Mechanism: Pharmacologically active on Toll-like receptor 2
Curator reviewed
Formula / weight: C₃₀H₄₉N₉O₉ · 679.776 g/mol (avg)
Code names: ORF-15244 · TP-5

Resolves to

Compound

UNIIO3Y80ZF13FCAS69558-55-0ChEMBLCHEMBL156025ChEBI135870PubChem451417

Clinical / RWD

RxNorm40230ATCL03AX09

Structure

InChIKeyPSWFFKRAVBDQEG-XXTQFKTOSA-NSMILESCC(C)C(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O

Targets

O60603TLR2

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 7 drug categories

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Thymopentin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account